Axsome Therapeutics (AXSM) Earnings Date, Estimates & Call Transcripts $131.15 -0.53 (-0.40%) Closing price 04:00 PM EasternExtended Trading$131.82 +0.67 (+0.51%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Axsome Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateMay. 5Before Market OpensEstimatedActual EPS (Nov. 12) -$1.34 Beat By $0.04 Consensus EPS (Nov. 12) -$1.38 Axsome Therapeutics posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$1.34, which topped analysts' consensus estimates of -$1.38 by $0.04. Quarterly revenue was reported to be $104.76 million, above analyst estimates of $98.71 million. With a trailing EPS of -$6.53, Axsome Therapeutics' earnings are expected to grow next year, from ($4.70) to ($2.01) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by AXSM Upcoming EarningsAxsome Therapeutics' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules, with a conference call scheduled for at 8:00 AM ET. Interested parties can register for or listen to the call. Get Axsome Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Axsome Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAXSM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AXSM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Axsome Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.71-$0.85-$1.25Q2 20254-$1.60-$0.55-$1.04Q3 20254-$1.16-$0.23-$0.69Q4 20254-$1.29$0.38-$0.36FY 202516-$5.76-$1.25-$3.34Q1 20261-$0.61-$0.61-$0.61Q2 20261-$0.23-$0.23-$0.23Q3 20261$0.04$0.04$0.04Q4 20261$0.06$0.06$0.06FY 20264($0.74)($0.74)($0.74) Axsome Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------11/12/2024Q3 2024-$1.38-$1.34+$0.04-$1.34$98.71M$104.76M8/5/2024Q2 2024-$1.30-$1.24+$0.06-$0.81$84.53M$87.17M5/6/2024Q1 2024-$1.20-$1.09+$0.11-$0.74$69.91M$75.00M2/20/2024Q4 2023-$1.21-$0.73+$0.48$0.62$70.38M$71.53M11/6/2023Q3 2023-$1.24-$1.32 -$0.08-$1.32$54.88M$57.79M8/7/2023Q2 2023-$1.24-$1.00+$0.24-$0.46$40.19M$46.70M5/8/2023Q1 2023-$1.13-$0.22+$0.91-$0.18$26.87M$94.58M2/27/2023Q4 2022-$1.18-$1.28 -$0.10-$1.15$21.51M$24.37M Axsome Therapeutics Earnings - Frequently Asked Questions When is Axsome Therapeutics's earnings date? Axsome Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on AXSM's earnings history. Did Axsome Therapeutics beat their earnings estimates last quarter? In the previous quarter, Axsome Therapeutics (NASDAQ:AXSM) reported ($1.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.38) by $0.04. Learn more on analysts' earnings estimate vs. AXSM's actual earnings. How can I listen to Axsome Therapeutics's earnings conference call? The conference call for Axsome Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Axsome Therapeutics's conference call transcript? The conference call transcript for Axsome Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Axsome Therapeutics generate each year? Axsome Therapeutics (NASDAQ:AXSM) has a recorded annual revenue of $270.60 million. How much profit does Axsome Therapeutics generate each year? Axsome Therapeutics (NASDAQ:AXSM) has a recorded net income of -$239.24 million. AXSM has generated -$6.53 earnings per share over the last four quarters. What is Axsome Therapeutics's EPS forecast for next year? Axsome Therapeutics's earnings are expected to grow from ($4.70) per share to ($2.01) per share in the next year. More Earnings Resources from MarketBeat Related Companies Teva Pharmaceutical Industries Earnings Date BeiGene Earnings Date Summit Therapeutics Earnings Date Intra-Cellular Therapies Earnings Date Viatris Earnings Date Genmab A/S Earnings Date Moderna Earnings Date Dr. Reddy's Laboratories Earnings Date Sarepta Therapeutics Earnings Date Vaxcyte Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?Earnings Miss? Amgen’s Dividend Still a Bright SpotPalantir Stock Surges After Blockbuster Earnings: What's Next?Atlassian: Upside Still in Play After Impressive Earnings SpikeWhy Amazon’s Next Earnings Could Trigger a Stock Breakout This page (NASDAQ:AXSM) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMarket down? Do this now.The Trump administration's new tariffs have already begun to shake the economy. The impact is real, and the cl...Colonial Metals | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | SponsoredCentral Bank Abandons USDWarren Buffett Dumping Stocks at Record Levels… Discover how savvy Americans are positioning their retireme...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.